These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32799573)

  • 61. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
    Liang D; Bao Y; Wallace M; Grant I; Shi Y
    Addiction; 2018 Nov; 113(11):2060-2070. PubMed ID: 29989239
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever.
    Shi Y
    Drug Alcohol Depend; 2017 Apr; 173():144-150. PubMed ID: 28259087
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Medical marijuana laws (MMLs) and dispensary provisions not associated with higher odds of adolescent marijuana or heavy marijuana use: A 46 State Analysis, 1991-2015.
    Johnson JK; Johnson RM; Hodgkin D; Jones AA; Kritikos A; Doonan SM; Harris SK
    Subst Abus; 2021; 42(4):471-475. PubMed ID: 33750275
    [No Abstract]   [Full Text] [Related]  

  • 65. Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review.
    Bonar EE; Coughlin L; Roche JS; Philyaw-Kotov ML; Bixler EA; Sinelnikov S; Kolosh A; Cihak MJ; Cunningham RM; Walton MA
    Prev Med; 2020 Mar; 132():105972. PubMed ID: 31904397
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Heterogeneous health effects of medical marijuana legalization: Evidence from young adults in the United States.
    Chay J; Kim S
    Health Econ; 2022 Feb; 31(2):269-283. PubMed ID: 34755415
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Marijuana users are likely to report opioid misuse among adults over 50 years in representative sample of the United States (2002-2014).
    Ramadan MM; Banta JE; Bahjri K; Montgomery SB
    J Addict Dis; 2021; 39(1):66-73. PubMed ID: 32935646
    [No Abstract]   [Full Text] [Related]  

  • 68. The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.
    Mauri AI; Townsend TN; Haffajee RL
    Milbank Q; 2020 Mar; 98(1):57-105. PubMed ID: 31800142
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use.
    Shah A; Hayes CJ; Lakkad M; Martin BC
    J Gen Intern Med; 2019 Aug; 34(8):1419-1426. PubMed ID: 30684198
    [TBL] [Abstract][Full Text] [Related]  

  • 70. As opioid overdose deaths reach record highs, call for systematic changes grows louder.
    ED Manag; 2016 Feb; 28(2):13-9. PubMed ID: 26939351
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Federal Response to the Opioid Crisis.
    Johnson K; Jones C; Compton W; Baldwin G; Fan J; Mermin J; Bennett J
    Curr HIV/AIDS Rep; 2018 Aug; 15(4):293-301. PubMed ID: 29968173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Opioid Epidemic in the United States.
    Wilkerson RG; Kim HK; Windsor TA; Mareiniss DP
    Emerg Med Clin North Am; 2016 May; 34(2):e1-e23. PubMed ID: 27133253
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medical and non-medical cannabis use and risk of prescription opioid use disorder: Findings from propensity score matching.
    Liang D; Wallace MS; Shi Y
    Drug Alcohol Rev; 2019 Sep; 38(6):597-605. PubMed ID: 31347204
    [TBL] [Abstract][Full Text] [Related]  

  • 74. How Are Telehealth Laws Intersecting With Laws Addressing the Opioid Overdose Epidemic?
    Pepin D; Hulkower R; McCord RF
    J Public Health Manag Pract; 2020; 26(3):227-231. PubMed ID: 31348152
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids.
    Bedene A; Dahan A; Rosendaal FR; van Dorp ELA
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1081-1094. PubMed ID: 36068971
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update.
    Brady KT; McCauley JL; Back SE
    Am J Psychiatry; 2016 Jan; 173(1):18-26. PubMed ID: 26337039
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The opioid epidemic is an historic opportunity to improve both prevention and treatment.
    DuPont RL
    Brain Res Bull; 2018 Apr; 138():112-114. PubMed ID: 28627395
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.
    Kolodny A; Courtwright DT; Hwang CS; Kreiner P; Eadie JL; Clark TW; Alexander GC
    Annu Rev Public Health; 2015 Mar; 36():559-74. PubMed ID: 25581144
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect Of A "No Superuser Opioid Prescription" Policy On ED Visits And Statewide Opioid Prescription.
    Kahler ZP; Musey PI; Schaffer JT; Johnson AN; Strachan CC; Shufflebarger CM
    West J Emerg Med; 2017 Aug; 18(5):894-902. PubMed ID: 28874942
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Misclassification of Medical Marijuana.
    Krystal H
    J Am Acad Psychiatry Law; 2018 Dec; 46(4):472-479. PubMed ID: 30593477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.